Tty Biopharm Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tty Biopharm Company Limited with three other
companies in this sector in Taiwan:
Formosa Laboratories, Inc
sales of 3.19 billion Taiwanese Dollars [US$104.74 million]
of which 100%
was Active Pharmaceutical Ingredient),
Standard Chem. & Pharm. Co Ltd
(3.67 billion Taiwanese Dollars [US$120.65 million]
of which 64%
was Standard), and
Pharmally International Holding Co Ltd
(4.33 billion Taiwanese Dollars [US$142.34 million]
Tty Biopharm Company Limited reported sales of 3.76 billion Taiwanese Dollars (US$123.50 million)
December of 2016.
increase of 17.7%
versus 2015, when the company's sales were 3.20 billion Taiwanese Dollars.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Tty Biopharm Company Limited had sales
of 3.87 billion Taiwanese Dollars.
Sales of Anti-Infection Drug saw an increase
that was more than double the company's growth rate: sales were up
63.9% in 2016, from
310.06 million Taiwanese Dollars to 508.11 million Taiwanese Dollars.
Tty Biopharm Company Limited also saw significant increases in sales in
Other (up 43.4% to 17.09 million Taiwanese Dollars)
Not all segments of Tty Biopharm Company Limited experienced an increase in sales in 2016:
sales of Mainland fell 8.3% to 64.70 million Taiwanese Dollars.
(However, this segment's sales were only a very small portion of the company's overall sales).
Tty Biopharm Company Limited also experienced decreases in sales in
Cardiovascular and Gastrointestinal Drug (down 4.1% to 492.47 million Taiwanese Dollars)
Taipei Branch (down 0.7% to 205.16 million Taiwanese Dollars)